denounced the lack of solid studies that the effectiveness of treatments for children in venous thrombosis testen
19 th Congress national of the chapter Spanish of Phlebology.
– This is a disease which, although it is less common in children than in adults, primarily affects infants and adolescents (almost always in the context of other serious illnesses requiring care in intensive care units).
– due to its low frequency – yearly affects about one in every 100,000 children-, the recommendations in that treatments refers are usually based on extrapolations of treatments in adults.
Bilbao, 2011-April on this subject has lectured the doctor Julio Romero González, pediatrician of the Hospital Universitario Virgen de las Nieves, in a talk titled special issue of the diagnosis and treatment of Venosa thromboembolic disease (ETEV) in the Pediatric ” held in the framework of the nineteenth Congress national of the chapter Spanish of Phlebology which took place from 7 to the April 9 at the Hotel Abade Nevada Palace in Granada.
the event brings together some 150 experts in the field of Phlebology to, among other things, address the new challenges of the specialty in the 21st century. In addition, the Congress, addressed as a central theme – as well as territories deep thromboembolic disease (Gynecology, Pediatrics and cancer) – frontier, pelvic venous disease, will host the presentation of the consensus of laser Endovenoso of the Spanish chapter of Phlebology, pioneer in Europe, and the clinical guidelines of sclerotherapy
this type of disease manifests itself in the acute form, some of them with high mortality, that sometimes are chronic effects in survivors ”, explained the expert.
on the other hand, the speaker warned that because of its low frequency, few studies to test the effectiveness of the different proposed treatments, so recommendations are usually based on extrapolations of treatments in adults ”.
on preventive measures, the three main ones are: restrict to a minimum the use of central venous catheters, a careful use of them when they are needed, and prophylactic anticoagulation in highly selected patients ”, stated Dr. Romero.